Doherty TM - Search Results

1

Specific immune-based diagnosis of tuberculosis.

Andersen P, Munk ME, Pollock JM, Doherty TM. Andersen P, et al. Among authors: doherty tm. Lancet. 2000 Sep 23;356(9235):1099-104. doi: 10.1016/s0140-6736(00)02742-2. Lancet. 2000. PMID: 11009160 Review.

2

Tuberculosis vaccines: developmental work and the future.

Doherty TM, Andersen P. Doherty TM, et al. Curr Opin Pulm Med. 2000 May;6(3):203-8. doi: 10.1097/00063198-200005000-00007. Curr Opin Pulm Med. 2000. PMID: 10782704 Review.

3

Long-lived immune response to early secretory antigenic target 6 in individuals who had recovered from tuberculosis.

Wu-Hsieh BA, Chen CK, Chang JH, Lai SY, Wu CH, Cheng WC, Andersen P, Doherty TM. Wu-Hsieh BA, et al. Among authors: doherty tm. Clin Infect Dis. 2001 Oct 15;33(8):1336-40. doi: 10.1086/323044. Epub 2001 Sep 14. Clin Infect Dis. 2001. PMID: 11565073

4

Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients.

Doherty TM, Demissie A, Olobo J, Wolday D, Britton S, Eguale T, Ravn P, Andersen P. Doherty TM, et al. J Clin Microbiol. 2002 Feb;40(2):704-6. doi: 10.1128/jcm.40.2.704-706.2002. J Clin Microbiol. 2002. PMID: 11826002 Free PMC article.

5

Tuberculosis vaccine development.

Doherty TM, Andersen P. Doherty TM, et al. Curr Opin Pulm Med. 2002 May;8(3):183-7. doi: 10.1097/00063198-200205000-00006. Curr Opin Pulm Med. 2002. PMID: 11981306 Review.

6

Oral vaccination with subunit vaccines protects animals against aerosol infection with Mycobacterium tuberculosis.

Doherty TM, Olsen AW, van Pinxteren L, Andersen P. Doherty TM, et al. Infect Immun. 2002 Jun;70(6):3111-21. doi: 10.1128/iai.70.6.3111-3121.2002. Infect Immun. 2002. PMID: 12011005 Free PMC article.

7

Selecting the components for a safe and efficient tuberculosis subunit vaccine--recent progress and post-genomic insights.

Okkels LM, Doherty TM, Andersen P. Okkels LM, et al. Among authors: doherty tm. Curr Pharm Biotechnol. 2003 Feb;4(1):69-83. doi: 10.2174/1389201033377931. Curr Pharm Biotechnol. 2003. PMID: 12570683 Review.

8

The potential of recombinant antigens ESAT-6, MPT63 and mig for specific discrimination of Mycobacterium tuberculosis and M. avium infection.

Rolinck-Werninghaus C, Magdorf K, Stark K, Lyashchenko K, Gennaro ML, Colangeli R, Doherty TM, Andersen P, Plum G, Herz U, Renz H, Wahn U. Rolinck-Werninghaus C, et al. Among authors: doherty tm. Eur J Pediatr. 2003 Jul;162(7-8):534-536. doi: 10.1007/s00431-003-1199-6. Epub 2003 Apr 25. Eur J Pediatr. 2003. PMID: 12715165 No abstract available.

9

Combination of the cationic surfactant dimethyl dioctadecyl ammonium bromide and synthetic mycobacterial cord factor as an efficient adjuvant for tuberculosis subunit vaccines.

Holten-Andersen L, Doherty TM, Korsholm KS, Andersen P. Holten-Andersen L, et al. Among authors: doherty tm. Infect Immun. 2004 Mar;72(3):1608-17. doi: 10.1128/iai.72.3.1608-1617.2004. Infect Immun. 2004. PMID: 14977968 Free PMC article.

10

Comparative analysis of different vaccine constructs expressing defined antigens from Mycobacterium tuberculosis.

Doherty TM, Olsen AW, Weischenfeldt J, Huygen K, D'Souza S, Kondratieva TK, Yeremeev VV, Apt AS, Raupach B, Grode L, Kaufmann S, Andersen P. Doherty TM, et al. J Infect Dis. 2004 Dec 15;190(12):2146-53. doi: 10.1086/425931. Epub 2004 Nov 8. J Infect Dis. 2004. PMID: 15551213

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results